GSK says tests show Vir antibody drug works against Omicron
Dec 2 (Reuters) - GlaxoSmithKline on Thursday said that a pre-clinical analysis of the antibody-based COVID-19 therapy it is developing with U.S. partner Vir has indicated that the drug also works against the new Omicron variant.Further tests wil...
Read more